Zygomatic Implants: Success Rates, Risks & Complications

Zygomatic implants have been placed since the late 1980s and followed in clinical studies for more than 25 years. Published pooled analyses put long-term survival at around 95–96%: one meta-analysis of 4,556 implants reports 95.21% cumulative survival at twelve years [1], and the 2023 ITI consensus review reports 96.2% over a mean follow-up of 6.3 years [6]. That is broadly comparable with conventional implants in healthy jawbone. Whether they suit your own jaw is a separate question — see who is and is not a candidate.

That number needs context rather than celebration. Survival means the implant is still in place and carrying a bridge; it does not mean treatment was free of problems along the way. Most published series come from surgeons who place these implants regularly, often in university or referral settings, and results from that environment cannot be transferred to a practice handling a handful of cases a year.

What matters just as much is the comparison. If your upper jaw has severe bone loss, the realistic alternatives are extensive bone grafting followed by conventional implants, or continuing with a removable denture — each with its own risks and trade-offs. The honest question is not whether this surgery carries risk, because all surgery does, but whether the balance suits your anatomy and priorities. See all the options when bone is limited.

Reported frequencies vary widely between published series depending on technique, case complexity and length of follow-up, so no single percentage can be quoted responsibly here — ask your surgeon which figures they use and where they come from [2]. A clinic that will not walk you through the whole list below before you consent is not giving you what you need to decide. If a complication does develop, what happens when a zygomatic implant fails covers removal, revision and where the NHS will and will not step in.

If you take one thing from this page, take this: with zygomatic implants, who operates matters more than the implant brand, the city or the price. The complications above are overwhelmingly technique-dependent, and placing a 30–52.5 mm implant along a path bounded by the sinus and the orbit demands anatomical experience a general implant dentist may simply not have.

That is not a criticism of implant dentists; it is an argument for asking direct questions and expecting specific answers. Volume is not the whole story — planning discipline, CBCT-based case selection and a clear complication pathway matter too — but a surgeon who cannot say how many zygomatic arches they completed last year has given you no way to judge any of it. Vague reassurance, or reluctance to discuss failures, tells you something important. Our guide to checking a zygomatic surgeon turns that into questions you can actually ask.

Pooled analyses report survival of around 95–96% — 95.21% cumulative at twelve years [1], and 96.2% over a mean 6.3-year follow-up [6]. Individual long-follow-up series describe implants still functioning beyond fifteen years [7]. Published follow-up does not currently extend much past that, so nobody can honestly quote a lifetime figure. Three further caveats belong with these numbers.

The implants and the teeth attached to them have different lifespans — the bridge is a wearing component that may need repair or renewal well before the implants do, a recurring cost our cost guide covers. Those figures also describe maintained implants in patients who attended reviews; outcomes in people who stop attending are not what the survival literature measures. And an average is not a prognosis: bone quality, sinus health, smoking, bite forces and surgical skill all shift your individual outlook in both directions. A clinician who has seen your scan can discuss your case; a website cannot.